• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles Aminothiazoles

Research Brief on Ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylate (CAS: 134136-00-8)

Ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylate (CAS: 134136-00-8) is a benzothiazole derivative that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This compound, characterized by its unique heterocyclic structure, has been explored for its pharmacological properties, including neuroprotective, anti-inflammatory, and anticancer activities. The benzothiazole core is a privileged scaffold in drug design, often associated with diverse biological activities, making this compound a promising candidate for further investigation.

Recent studies have focused on the synthesis and optimization of ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylate to enhance its bioavailability and therapeutic efficacy. Researchers have employed various synthetic routes, including multi-step organic reactions, to produce this compound with high purity and yield. Advanced spectroscopic techniques, such as NMR and mass spectrometry, have been utilized to confirm its structural integrity. These efforts are critical for ensuring the compound's suitability for preclinical and clinical studies.

One of the key areas of interest is the compound's potential as a neuroprotective agent. In vitro and in vivo studies have demonstrated its ability to modulate oxidative stress and reduce neuronal damage, suggesting possible applications in neurodegenerative diseases such as Alzheimer's and Parkinson's. Additionally, its anti-inflammatory properties have been investigated, with promising results indicating its potential to inhibit pro-inflammatory cytokines and pathways. These findings highlight the compound's versatility and therapeutic potential.

Another significant aspect of recent research involves the exploration of ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylate in oncology. Preliminary studies have shown that this compound can induce apoptosis in certain cancer cell lines, possibly through the inhibition of key signaling pathways. Researchers are also investigating its synergistic effects with existing chemotherapeutic agents, aiming to enhance treatment outcomes while minimizing side effects. These studies are still in the early stages, but the results are encouraging.

Despite the promising findings, challenges remain in the development of ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylate as a therapeutic agent. Issues such as solubility, metabolic stability, and potential toxicity need to be addressed through further structural modifications and pharmacokinetic studies. Collaborative efforts between chemists, biologists, and pharmacologists are essential to overcome these hurdles and advance the compound toward clinical trials.

In conclusion, ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylate (CAS: 134136-00-8) represents a promising molecule with diverse pharmacological applications. Ongoing research is focused on optimizing its properties and elucidating its mechanisms of action, paving the way for its potential use in treating various diseases. As the scientific community continues to explore this compound, it is expected to play a significant role in the future of drug discovery and development.

• 866033-94-5(Ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylate hydrobromide)
• 866034-01-7(2-acetamido-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylic acid)
• 78468-68-5(Ethyl 2-(2-amino-4-methylthiazol-5-yl)acetate)
• 134136-02-0(methyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylate)
• 1019108-35-0(ethyl 2-amino-4H,5H,6H-cyclopenta[d][1,3]thiazole-4-carboxylate)
• 76263-11-1(Ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylate)
• 77528-46-2(4-Ethoxycarbonyl-4,5,6,7-tetrahydro-benzo[d]thiazole)
• 40440-23-1(2-Amino-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylic acid)
• 134136-03-1(2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-6-carboxylic acid)
• 40440-22-0(ethyl 2-amino-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylate hydrochloride)